Yuanxiang Tu

1PUBLICATIONS
1CO-AUTHORS
Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 23, 2022
Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment.

Di Li, Yuanxiang Tu, Kaijun Jin

Pageof 1

Frequent Collaborators

1 joint publications

Hai Qian